Delivery Order SPE2DB22D3016-SPE2DB25FBGG1
- Not listed
- The Defense Logistics Agency awarded a $9,819.56 delivery order to AmerisourceBergen Drug Corp for Clomid 50 mg tablets (30-count unit dose packaging) on August 8, 2025, with an ultimate completion date of August 11, 2025. This non-set-aside, firm fixed-price delivery order represents a competitive award under an existing contract vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- The Defense Logistics Agency awarded a $35,627.20 delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Clomid 50 mg tablets in unit dose packs of 30 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 22, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $3,513.70 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30s) on September 12, 2025, with an ultimate completion date of September 15, 2025. The contract utilizes firm fixed price pricing and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,110.93 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-unit supplies). The contract, issued on July 10, 2025, with an ultimate completion date of July 11, 2025, represents a firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location, demonstrating...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,789.18 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging of 10s. This competitively awarded, non-set-aside contract was finalized on April 22, 2025, with an ultimate completion date of April 23, 2025, and represents a firm fixed-price delivery order. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packaging (30-count) with a ceiling value of $1,224.98. The contract, awarded on September 19, 2025, is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is one of the nation's leading...
- The Defense Logistics Agency awarded a $1,648.70 delivery order to AmerisourceBergen Drug Corp for Clomid 50 mg tablets in unit-dose packs of 30. This is a firm fixed-price, non-set-aside contract awarded on September 24, 2025, with an ultimate completion date of September 25, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,250.85 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets (30-unit dose) on August 21, 2025, with a completion date of August 22, 2025. This firm fixed price delivery order represents a competitive award with no set-aside designation and will be performed at the vendor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves...
- The Defense Logistics Agency awarded a $1,137.71 delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Clomid 50 mg tablets in unit dose packaging of 30 tablets. This is a firm fixed price, non-set-aside contract with a completion date of July 9, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $8,677.23 to AmerisourceBergen Drug Corp for the supply of Clomid 50 mg tablets in unit dose packages of 30 units. This firm fixed-price delivery order, awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBGG1Delivery Order
The Defense Logistics Agency awarded a $3,766.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Clomid 50 mg tablets (30-count unit dose packaging) with an ultimate completion date of August 27, 2025. This competitively awarded, non-set-aside contract represents a single delivery order fulfilling pharmaceutical supply requirements for federal medical procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 comprehensive pharmaceutical support vehicle extending through December 2026. The parent IDC enables the contractor to supply a wide range of pharmaceutical products and medical supplies globally to support military healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The current award reflects the company's demonstrated capability to fulfill federal medical supply requirements within the DLA's pharmaceutical prime vendor framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 8/26/25 |